CN1903351A - Funing gel prepn. and its prepn. method - Google Patents
Funing gel prepn. and its prepn. method Download PDFInfo
- Publication number
- CN1903351A CN1903351A CNA2006101096755A CN200610109675A CN1903351A CN 1903351 A CN1903351 A CN 1903351A CN A2006101096755 A CNA2006101096755 A CN A2006101096755A CN 200610109675 A CN200610109675 A CN 200610109675A CN 1903351 A CN1903351 A CN 1903351A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight portion
- hours
- water
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
A Chinese medicine 'Funing gel' for treating gynopathy by percuteneous absorption and its preparing process are disclosed.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, peaceful gel preparation of specifically a kind of woman and preparation method thereof.
Background technology
By Radix Sophorae Flavescentis, Cortex Phellodendri, Radix Scutellariae etc. ten simply the peaceful vagina administration preparation of woman formed of Chinese medicine have the function of heat-clearing and toxic substances removing, removing dampness and killing parasites, removing the necrotic tissue and promoting granulation, blood-activating analgetic, be used for vaginitis that antibacterial, virus, mycete, infusorian etc. cause, ulcer of vagina, cervicitis, cervical erosion etc. and have significant curative effect.The Radix Sophorae Flavescentis external has good heat clearing and damp drying in the side, and the effect of detoxifcation killing parasites for relieving itching is so be monarch drug.Be equipped with the merit of the heat-clearing and toxic substances removing dampness of Cortex Phellodendri, Radix Scutellariae, with the merit of principal drug assistance heat-clearing and toxic substances removing, so be ministerial drug.And the Rhizoma Curcumae power of invigorating blood circulation is strong in the side, can reach the merit of removing blood stasis reducing swelling and alleviating pain, the kind heat-clearing and toxic substances removing of Pulvis Fellis Suis merit is with detumescence, Concha Meretricis Seu Cyclinae powder, Plumbum preparatium, catechu all have the effect that removing dampness is held back skin ulcer, but Olibanum, Myrrha, Borneolum Syntheticum again all detumescence and promoting granulation hold back skin ulcer, each medicine both can help the merit of monarch-minister drug dampness detoxifcation, can reach detumescence again and hold back the effect of skin ulcer, so be adjuvant drug altogether.Make a general survey of Quan Fanggong and concentrate one's efforts greatly, mutually collaborative, play the effect that heat clearing and damp drying, killing parasites for relieving itching, detoxifcation are held back skin ulcer altogether.
Preparation on this side basis has FUNINGSHUAN (to record standard numbering: WS3-B-3816-98) for the 20 of the Sanitation Ministry medicine standard " Chinese traditional patent formulation preparation " at present.The soft capsule suppository that the peaceful prescription of woman makes, vaginal tablet, vagina speed disintegrating tablet, vagina effervescence, vaginal capsule are disclosed among the CN1745837A, and in claim 1, point out can be made into other various vagina administration preparations except that ordinary suppository, as ordinary tablet, fast disintegrating tablet, effervescent tablet, capsule, type of effervescent suppository, soft capsule suppository, gel, foam, ointment, membrane.The peaceful effervescent tablet of concrete woman is disclosed among the CN1732398A.
But vaginal suppository storage inconvenience requires protecting below 30 ℃, uses at some high temperature severe cold areas to be subjected to certain restriction.And comprise other vaginal preparation of vaginal suppository, as fast disintegrating tablet, effervescent tablet, capsule, suppository, foam, ointment, membrane, ubiquity easily comes off from tract, the tract inner membrance is had zest, is difficult to shortcomings such as long-time storage-stable.In order better to improve patient's adaptability, should on the prescription basis of FUNINGSHUAN, carry out modified form to it, address these problems.Simultaneously, existing only have a kind of dosage form of FUNINGSHUAN to go on the market, and dosage form is single, can not satisfy the medication demand of vast female patient.
Gel is a kind of new formulation that grows up for meeting clinical needs in recent years, it is that the medical high-molecular additive (as carbomer, Carboxymethyl cellulose sodium, polyvinylpyrrolidone, polyvinyl alcohol etc.) that utilizes some new punishment is made gel with medicine, improve medicine local concentration, the release of prolong drug or the purpose of diffusion process thereby reach, have than other dosage form bioavailability height, good stability, the characteristics that untoward reaction is few.With medicine dissolution or be dispersed in and be gel in the gel, it can the long period and the site of action tight adhesion, and better biocompatibility is arranged, and method for making is simple, uses comfortable." Chinese pharmacopoeia 2000 editions has defined gel in two notes on the use: " gel is meant the latex glop or the semi-solid preparation of homogeneous, suspendible or emulsion-type that medicine and the adjuvant that can form gel are made." in modern pharmacy, be slow release, the controlled release form of substrate with the gel; obtained comprehensive research as gastric retention controlled release system, gel matrix tablet, exterior-applied gel etc.; the medicine that is applicable to the gel delivery system has hydrophilic medicament, hydrophobic drug, acidic drug, cationic drug, macromolecular drug, cell tissue etc.; can be from the oral cavity, number of ways administration such as nasal cavity, eye mucosa, gastrointestinal mucosal, vagina, rectum, skin; Chinese medicine gel generally mostly is percutaneous or mucosa delivery, is usually used in aspects such as anti-inflammatory and antalgic, antiviral, pain relieving at present.
But in the gel dosage form, also there are some problems,, usually need to use to promote penetrating agent, as azone for example in order to promote the osmotic absorption of drug administration position to medicine.And existing report azone causes it to make cell membrane function produce irreversibility and changes owing to similar with cell membrane constituent on its chemical constitution.And use too much promotion penetrating agent also can cause release inhomogeneous.For herbal mixture,, on physicochemical property, physiologically active, may there be a lot of differences between the various extracts, in addition as hydroaropic substance, lyophobic dust, volatilization wet goods owing to there is the extract of multi-flavor medicinal plants.If substrate is not added screening, may cause the active component in the herbal mixture, can not discharge synchronously, cause the drug effect of Chinese medicine effectively to bring into play.Stability during the depositing of gel also is the problem that needs solve in addition.
Therefore, rather write out a prescription at the woman, in order to solve the problem that exists in existing preparation such as the suppository, though it can be made gel according to conventional thinking, but still need on choice of base, pay performing creative labour, make that Funing gel curative effect on the basis that addresses the above problem is reliable, the patient uses comfortable.
Summary of the invention
The objective of the invention is to overcome the deficiency of prior art, a kind of scalable, good effect that has is provided, the peaceful preparation of the woman of nonirritant, compliance advantages of higher, the standard of improving the quality of products simultaneously further satisfies and ensures the medication demand of vast female patient.
Another object of the present invention provides the preparation method of described Funing gel.
Purpose of the present invention can take following method to realize: a kind of Funing gel is characterized in that it is that component is formed or made active component and pharmaceutically acceptable gel substrate is formed gel by the extract of following main materials by following main materials.
Radix Sophorae Flavescentis 300-3000 weight portion, Cortex Phellodendri 200-2000 weight portion, Radix Scutellariae 150-1500 weight portion, Rhizoma Curcumae 100-1000 weight portion, Concha Meretricis Seu Cyclinae powder 40-400 weight portion, Plumbum preparatium 6-60 weight portion, catechu 6-60 weight portion, Olibanum 3-30 weight portion, Myrrha 3-30 weight portion, Pulvis Fellis Suis 9-90 weight portion, Borneolum Syntheticum 1-10 weight portion.
Its formula optimization is:
Radix Sophorae Flavescentis 1370 weight portions, Cortex Phellodendri 820 weight portions, Radix Scutellariae 682 weight portions, Rhizoma Curcumae 410 weight portions, Concha Meretricis Seu Cyclinae powder 182 weight portions, Plumbum preparatium 27.3 weight portions, catechu 27.3 weight portions, Olibanum 13.6 weight portions, Myrrha 13.6 weight portions, Pulvis Fellis Suis 36.4 weight portions, Borneolum Syntheticum 5.5 weight portions.
Described pharmaceutically acceptable gel substrate is following one or more: aqueous gel substrate such as water, glycerol, propylene glycol, cellulose derivative (as methylcellulose, sodium carboxymethyl cellulose etc.), carbomer and alginate, tragacanth, pectin, gelatin, xanthan gum, agar; Non-cellulosic polysaccharide such as chitin, ethene polymers, acrylic resin, polyvinyl alcohol and carbopol etc.; Oil-base gel agent such as liquid paraffin and polyoxyethylene or fatty oil colloid silicon or wrong soap, zinc soap.
Preferred gel substrate is a carbomer.
If desired, gel of the present invention stabilizing agents such as adding wetting agent, antiseptic, pH value regulator, and additives that promote skin, mucosa absorption.Wherein the pH value regulator is selected from sodium hydroxide, sodium bicarbonate, sodium carbonate, potassium hydroxide, hydrochloric acid, sulphuric acid, nitric acid, phosphoric acid, triethanolamine etc.Preferred triethanolamine.Antiseptic is selected from benzyl alcohol, methyl hydroxybenzoate.Ethyl hydroxybenzoate, propyl hydroxybenzoate, phenol, chlorobutanol, thimerosal etc.Preferred ethyl hydroxybenzoate.
The preparation method of Funing gel of the present invention is as follows: above ten simply, Rhizoma Curcumae extracts volatile oil, aqueous solution after the distillation and medicinal residues and Radix Sophorae Flavescentis, Cortex Phellodendri and 91g Concha Meretricis Seu Cyclinae powder, decoct secondary, the first time, 7 times of water gagings were 2 hours, and the second time, 5 times of water gagings were 1.5 hours, collecting decoction, filter, filtrate is concentrated into relative density and is 1.04-1.06 (80 ℃ of surveys), and is standby.Radix Scutellariae decocts with water three times, the first time, 7 times of water gagings were 2 hours, each 5 times of water gaging of second and third time 1 hour, collecting decoction, filter, being concentrated into relative density is the clear paste of 1.05-1.08 (80 ℃ of surveys), adds hydrochloric acid (2mol/L) adjust pH 1.5-2.0 in the time of 80 ℃, and 80 ℃ are incubated 1 hour, quiet to 24 hours, filter, get precipitation, standby.Remaining 91g Concha Meretricis Seu Cyclinae powder, Plumbum preparatium, catechu, Olibanum, Myrrha, Pulvis Fellis Suis, Borneolum Syntheticum are pulverized mixing cross 100 mesh sieves, mix, grind evenly, take out through colloid mill with aforementioned standby extracting solution and precipitate, standby; The carbomer 934 of recipe quantity is evenly spread in the lapping liquid, make abundant swelling, placed 2 hours, with 80 ℃ of thermosols of ethyl hydroxybenzoate of Rhizoma Curcumae volatile oil and recipe quantity in the triethanolamine of recipe quantity, adding water dilutes in right amount, under the stirring of agitator, add in the swollen medicinal liquid of carbomer 934, add water to 5000g, stir, take out, fill, promptly.
Institute's referenced patents document and non-patent literature all are hereby incorporated by with its full content among the application.
The present invention is Chinese medicine extract arbitrarily, all can with pharmaceutically acceptable acid or alkali reaction, form corresponding salt.Preferred and the salifiable example of inorganic base shape comprises and alkali metal that the salt as sodium, potassium etc. form with alkaline-earth metal, as the salt that calcium, magnesium etc. form, reaches the salt that forms with aluminum, ammonium.Preferably the example of the salt that forms with organic base comprises trimethylamine, triethylamine, pyridine, ethanolamine, diethanolamine, triethanolamine, hexanamine, N, formed salt such as N-dibenzyl vinyl diamidogen.Preferred and the salifiable example of mineral acid shape comprises and formed salt such as hydrochloric acid, hydrobromic acid, nitric acid, sulphuric acid, phosphoric acid.Preferably with the salifiable example of organic acid institute shape comprise and formed salt such as formic acid, acetic acid, trichloroacetic acid, fumaric acid, oxalic acid, tartaric acid, maleic acid, citric acid, succinic acid, malic acid, methanesulfonic acid, benzenesulfonic acid, P-toluene sulfonic acide.Comprise and formed salt such as arginine, lysine, ornithine with the formed salt of basic amino acid that preferably the example of the salt of preferred and acidic amino acid institute property comprises formed salt such as glutamic acid, aspartic acid.
The present invention adopts through the preparation technology who optimizes, and determines the rational proportion of raw material, and pharmaceutically active ingredient height in the extraction improves curative effect of medication; Adopt gel technology, utilize gel and site of action closely to stick, have the characteristics of better bioadhesive, the increase medicine contacts with site of action, improves the curative effect of medicine; Adopt vagina administration, the onset piece.The peaceful gel preparation transdermal absorption factor of the woman height that adopts the present invention to make, steady quality, the active constituent content height, curative effect is reliable.
To more be expressly understood purpose of the present invention, characteristics and other advantage by the detailed description of carrying out, but they do not attempt in office where face limits the scope of the invention below in conjunction with embodiment.
Describe when of the present invention when the reference specific embodiments, it is evident that those skilled in the art without departing from the spirit and scope of the present invention down, will carry out multiple variation and modification to these embodiments.
Description of drawings
Fig. 1 is a flow sheet of the present invention.
Embodiment
One, the optimization of extraction process
The research of medicinal material extract process conditions such as 1 Radix Sophorae Flavescentis
Owing to the extracting parameter of three flavor medicines such as Radix Sophorae Flavescentis is not determined in the former FUNINGSHUAN standard, this technical study determines that to the water extraction decocting condition of three flavor medical materials such as Radix Sophorae Flavescentis test adopts single factor experiment to carry out preferably.The factor of test and Selection is an amount of water for the first time, and with the paste-forming rate of spissated dried cream as investigating index, EXPERIMENTAL DESIGN and the results are shown in following table.
Radix Sophorae Flavescentis extracts investigates test
| Tested number | Test arrangement | Result of the test | |
| 2 hours (doubly) for the first time | 1.5 hours (doubly) for the first time | Paste-forming rate (%) | |
| 1 2 3 | 8 7 6 | 5 5 5 | 37.9 39.7 33.6 |
From result of the test as can be known, the paste-forming rate that extracts with No. 27 times of amounts of test and 5 times of water gagings determines that than No. 1 and No. 3 test height this extracting parameter is the extracting parameter of technology.
2 Radix Scutellariae extraction process Study on Conditions
2.1 the mensuration of the baicalin rate of transform
Test is carried out assay by Radix Scutellariae being extracted each step, and with contained baicalin in the radix scutellariae medicinal materials relatively, rationally whether the extracting parameter that investigation is formulated (Radix Scutellariae 100g), and result of the test sees the following form:
Radix Scutellariae extracts investigates test
| Number of times | Amount of water (ml) | Receipts amount (ml) | Content of baicalin (mg) | Content of baicalin in the medical material (mg/g) |
| For the third time for the second time for the first time | 700 500 500 | 462 500 510 | 3759 1728 917 | 77.25 |
By the result as can be known, extract through three times, receive the baicalin total amount be 3759mg+1728mg+917mg=6404mg, corresponding medical material is 64.04mg/g, extraction ratio is 83.0%.
2.2 the acid precipitation process is to the influence of the baicalin rate of transform
Undertaken in the acid precipitation process of the test by Radix Scutellariae is extracted concentrated solution, receive under the different pH condition the baicalin crude product carried out assay, and compare with content of baicalin in the concentrated solution, determined more excellent pH scope, the results are shown in following table:
| Tested number | Medicine heavy (g) | PH value | Yield (%) |
| 1 2 3 | 50.1 49.9 51.1 | 1.01 1.54 2.05 | 95.4 99.0 100.7 |
By the result as can be known, Radix Scutellariae being extracted the reasonable pH scope that concentrated solution carries out acid precipitation should be between 1.5-2.0.
Two, the selection of gel substrate
The quality that the main investigation index of studying for medicament gelling agent is exactly its transdermal performance.Select suitable substrate to help to improve the Transdermal absorption ability of medicine.For Chinese medicine, because its complex chemical composition, when carrying out the Transdermal absorption aptitude tests, only can select a kind of or a few is explicitly known and become positively related chemical constituent as index with curative effect, show its Transdermal absorption ability.In the research to the FUNINGSHUAN agent, more is to use oxymatrine as index (referring to Fu Ke etc., oxymatrine concentration in the tlc scanning determination FUNINGSHUAN, Chinese medicine journal, 1996 (01), 54).Therefore, the application adopts oxymatrine as index, with reference to Wu Wanying etc., the research of Radix Sophorae Flavescentis total alkaloids percutaneous rate under the different pH value, the Chinese medicine journal, 1999 (2), method that 61-62 is disclosed is tested comparison to the Transdermal absorption of oxymatrine in the Funing gel of selecting different gel substrate for use.
1. grouping and administration
60 of Wister male rats, body weight 255.8 ± 29.6 is divided into 6 groups at random by body weight.Chinese medicine with FUNINGSHUAN agent prescription, according to above-mentioned preferred extraction process, obtain extract, then respectively with carbomer 934, Acritamer 940, Carbopol 941, methylcellulose, sodium carboxymethyl cellulose, cross linked sodium polyacrylate, make the peaceful gel preparation of corresponding woman according to above-mentioned preparation technology, the final content of its mesostroma is 3%, and regulates pH value to 6.5-7.0 with triethanolamine.
2. method is with reference to Wu Wanying etc., the research of Radix Sophorae Flavescentis total alkaloids percutaneous rate under the different pH value, Chinese medicine journal, 1999 (2), the disclosed method of 61-62.
3 results
| Group | Accumulation infiltration equation (μ g/cm 2) | J(μg/cm 2h) | r |
| Carbopol 941 | Q＝-112.939+92.562t | 92.562 | 0.9777 |
| Acritamer 940 | Q＝-18.339+21.765t | 21.765 | 0.9586 |
| Carbomer 934 | Q＝-97.521+82.869t | 82.869* | 0.9776 |
| Methylcellulose | Q＝-53.597+49.969t | 49.969 | 0.9666 |
| Sodium carboxymethyl cellulose | Q＝-88.199+58.757t | 58.757 | 0.9560 |
| Cross linked sodium polyacrylate | Q＝-76.130+51.689t | 51.689 | 0.9618 |
Annotating 1:J is the percutaneous rate constant, the transdermal throughput of unit are in the unit interval of display-object chemical compound.
Annotate each group of 2:* and other and compare p＜0.05 respectively.
This shows that the substrate of Funing gel is the most excellent with carbomer 934 on the promotion Transdermal absorption.
Three, the optimization of pH value
Prescription 1:
Suspension 146.9g such as Radix Sophorae Flavescentis
Rhizoma Curcumae volatile oil 0.08ml
Carbomer 934 4.4g
Triethanolamine 4.3g
Ethyl hydroxybenzoate 0.2g
Add water to 200g
Method for making: the carbomer 934 stirring of recipe quantity is dissolved in the Radix Sophorae Flavescentis suspension, places swelling; Oleum Curcumae and ethyl hydroxybenzoate are dissolved in triethanolamine for 70 ℃, add water and dilute in right amount, join while stirring in the swelling solution of carbomer, add water to 200g, promptly.
The result: Oleum Curcumae and ethyl hydroxybenzoate can be dissolved in the triethanolamine preferably, but speed is slower; Carbomer can be evenly distributed in the suspension of Radix Sophorae Flavescentis under continuous condition of stirring, through placing expansion gradually, form colloidal sol, behind the triethanolamine to be added, carries out high-speed stirred with agitator, because the introducing of OH-forms gel.The gel character that makes is better, is the sepia semi-solid, but pH is slightly high, reaches 7.0.
Prescription 2:
Suspension 147.8g such as Radix Sophorae Flavescentis
Rhizoma Curcumae volatile oil 0.08ml
Carbomer 934 6.1g
Triethanolamine 4.3g
Ethyl hydroxybenzoate 0.2g
Add water to 200g
Method for making: the carbomer 934 stirring of recipe quantity is dissolved in the Radix Sophorae Flavescentis suspension, places swelling; Oleum Curcumae and ethyl hydroxybenzoate are dissolved in triethanolamine for 70 ℃, add water and dilute in right amount, join while stirring in the swelling solution of carbomer, add water to 200g, promptly.
The result: suitable increase the consumption of carbomer, the consumption of triethanolamine is constant, it is 1 little that the gel viscosity that makes is write out a prescription, pH value reduces to 6.5.
Prescription 3:
Suspension 309.2g such as Radix Sophorae Flavescentis
Rhizoma Curcumae volatile oil 0.20ml
Carbomer 934 15.1g
Triethanolamine 22.5g
Ethyl hydroxybenzoate 0.5g
Add water to 500g
Method for making: the carbomer 934 stirring of recipe quantity is dissolved in the Radix Sophorae Flavescentis suspension, places swelling; Oleum Curcumae and ethyl hydroxybenzoate are dissolved in triethanolamine for 80 ℃, add water and dilute in right amount, join while stirring in the swelling solution of carbomer, add water to 500g, promptly.
The result: Oleum Curcumae and ethyl hydroxybenzoate are dissolved in the triethanolamine preferably, and speed is very fast; Increase on the basis of carbomer consumption, increase the consumption of triethanolamine, the gel viscosity that makes is moderate, and pH value is also below 7.0.
Through prescription screening, the percentage ratio that main ingredient in each prescription is accounted for the prescription total amount is summarized as follows:
| The prescription number | Ka Baimu 934 (%) | Triethanolamine (%) | Ethyl hydroxybenzoate (%) | pH | Viscosity * |
| 1 2 3 | 2.2 3.0 3.0 | 2.2 2.2 4.5 | 1.0 1.0 1.0 | 7.0 6.5 6.3 | + - + |
* viscosity evaluation :-lower slightly+moderate
Analyze by test tabulation: Ka Baimu 934 and the triethanolamine ratio in prescription is respectively 3% and 4.5% o'clock, prepared gel viscosity is moderate, be pseudoplastic fluid, has bigger yield value, promptly under certain external force effect, can not flow, be fit to the requirement of vagina administration, and with variation of temperature, mobile not bigger change can rest on medicine-feeding part for a long time; 3 pH that gel is surveyed that make write out a prescription in addition below 7.0, meet the medicine-feeding part environment and be weakly acidic requirement.Therefore test determines that prescription 3 is an optimal technical scheme.
Four, stable contrast test
Because preparation of the present invention is a semi-solid preparation, also there is the characteristic of liquid simultaneously in existing solid characteristic, so need to investigate the stability of gel preparation of the present invention.Prescription 3 preparations that make carried out light durability relatively during 5 kinds of gel preparations except that carbomer 934 that now obtained in the selection with gel substrate and pH value were preferred.
Get the above-mentioned preparation of respectively organizing, Continuous irradiation 10 days respectively at sampling in 0,5,10 day, is checked its appearance character, content, the results are shown in following table.
The result is investigated in the light durability test
| Group | 0 day | 5 days | 10 days |
| Carbopol 941 | 6.75 | 6.24 | 6.01 |
| Acritamer 940 | 6.49 | 6.21 | 6.00 |
| Prescription 3 | 6.84 | 6.78 | 6.27 |
| Methylcellulose | 6.52 | 6.75 | 6.12 |
| Sodium carboxymethyl cellulose | 6.47 | 6.34 | 5.94 |
| Cross linked sodium polyacrylate | 6.94 | 6.12 | 6.05 |
Annotate: data are content of baicalin in the table, in mg/g.
Obviously be better than other each group by write out a prescription as can be known 3 stability of data in the table.
Five, example of formulations
Prescription:
Radix Sophorae Flavescentis 1370g Cortex Phellodendri 820g
Radix Scutellariae 682g Rhizoma Curcumae 410g
Concha Meretricis Seu Cyclinae powder 182g Plumbum preparatium 27.3g
Catechu 27.3g Olibanum 13.6g
Myrrha 13.6g Pulvis Fellis Suis 36.4g
Borneolum Syntheticum 5.5g carbomer 934 NF 150g
Triethanolamine 225g ethyl hydroxybenzoate 5g
Add water to 5000g
2 preparation technologies
More than ten simply, Rhizoma Curcumae extracts volatile oil, aqueous solution after the distillation and medicinal residues and Radix Sophorae Flavescentis, Cortex Phellodendri and 91g Concha Meretricis Seu Cyclinae powder, decoction secondary, the first time, 7 times of water gagings were 2 hours, and the second time, 5 times of water gagings were 1.5 hours, collecting decoction, filter, filtrate is concentrated into relative density and is 1.04-1.06 (80 ℃ of surveys), and is standby.Radix Scutellariae decocts with water three times, the first time, 7 times of water gagings were 2 hours, each 5 times of water gaging of second and third time 1 hour, collecting decoction, filter, being concentrated into relative density is the clear paste of 1.05-1.08 (80 ℃ of surveys), adds hydrochloric acid (2mol/L) adjust pH 1.5-2.0 in the time of 80 ℃, and 80 ℃ are incubated 1 hour, quiet to 24 hours, filter, get precipitation, standby.Remaining 91g Concha Meretricis Seu Cyclinae powder, Plumbum preparatium, catechu, Olibanum, Myrrha, Pulvis Fellis Suis, Borneolum Syntheticum are pulverized mixing cross 100 mesh sieves, mix, grind evenly, take out through colloid mill with aforementioned standby extracting solution and precipitate, standby; The carbomer 934 NF of recipe quantity is evenly spread in the lapping liquid, make abundant swelling, placed 2 hours, with 80 ℃ of thermosols of ethyl hydroxybenzoate of Rhizoma Curcumae volatile oil and recipe quantity in the triethanolamine of recipe quantity, adding water dilutes in right amount, under the stirring of agitator, add in the swollen medicinal liquid of carbomer 934 NF, add water to 5000g, stir, take out, fill, promptly.
In sum, gel preparation of the present invention all is better than conventional the selection at aspects such as stability, Transdermal absorption, and these effects obviously are not medicine or adjuvants itself, or dosage form itself is brought.Therefore, the application's technical scheme is paid creative work than prior art.Thereby the application's technical scheme is creative.
Claims (3)
1, a kind of Chinese medicine gel preparation, it is composed as follows: in parts by weight: Radix Sophorae Flavescentis 300-3000 weight portion, Cortex Phellodendri 200-2000 weight portion, Radix Scutellariae 150-1500 weight portion, Rhizoma Curcumae 100-1000 weight portion, Concha Meretricis Seu Cyclinae powder 40-400 weight portion, Plumbum preparatium 6-60 weight portion, catechu 6-60 weight portion, Olibanum 3-30 weight portion, Myrrha 3-30 weight portion, Pulvis Fellis Suis 9-90 weight portion, Borneolum Syntheticum 1-10 weight portion, 5 parts of 225 parts of ethyl hydroxybenzoates of 150 parts of triethanolamine of carbomer 934
Add water to 5000 parts
More than ten simply, Rhizoma Curcumae extracts volatile oil, aqueous solution after the distillation and medicinal residues and Radix Sophorae Flavescentis, Cortex Phellodendri and 91 parts of Concha Meretricis Seu Cyclinae powders, decoction secondary, the first time, 7 times of water gagings were 2 hours, and the second time, 5 times of water gagings were 1.5 hours, collecting decoction, filter, filtrate is concentrated into relative density and is 1.04-1.06 (80 ℃ of surveys), and is standby; Radix Scutellariae decocts with water three times, the first time, 7 times of water gagings were 2 hours, each 5 times of water gaging of second and third time 1 hour, collecting decoction, filter, being concentrated into relative density is the clear paste of 1.05-1.08 (80 ℃ of surveys), adds 2mol/L hydrochloric acid adjust pH 1.5-2.0 in the time of 80 ℃, and 80 ℃ are incubated 1 hour, quiet to 24 hours, filter, get precipitation, standby; Remaining 91 parts of Concha Meretricis Seu Cyclinae powders, Plumbum preparatium, catechu, Olibanum, Myrrha, Pulvis Fellis Suis, Borneolum Syntheticum are pulverized mixing cross 100 mesh sieves, mix, grind evenly, take out through colloid mill with aforementioned standby extracting solution and precipitate, standby; The carbomer 934 of recipe quantity is evenly spread in the lapping liquid, make abundant swelling, placed 2 hours, with 80 ℃ of thermosols of ethyl hydroxybenzoate of Rhizoma Curcumae volatile oil and recipe quantity in the triethanolamine of recipe quantity, adding water dilutes in right amount, under the stirring of agitator, add in the swollen medicinal liquid of carbomer 934, add water to 5000 parts, stir, take out, fill, promptly.
2, the peaceful gel preparation of woman as claimed in claim 1, wherein:
820 parts of 1370 portions of Cortex Phellodendris of Radix Sophorae Flavescentis
410 parts of 682 parts of Rhizoma Curcumae of Radix Scutellariae
27.3 parts of 182 parts of Plumbum preparatium of Concha Meretricis Seu Cyclinae powder
13.6 parts of 27.3 parts of Olibanums of catechu
36.4 parts of 13.6 parts of Pulvis Fellis Suiss of Myrrha
5.5 parts of Borneolum Syntheticums
3, the preparation method of gel preparation as claimed in claim 1 or 2, it is characterized in that: Rhizoma Curcumae extracts volatile oil, aqueous solution after the distillation and medicinal residues and Radix Sophorae Flavescentis, Cortex Phellodendri and 91 parts of Concha Meretricis Seu Cyclinae powders, decoct secondary, the first time, 7 times of water gagings were 2 hours, and the second time, 5 times of water gagings were 1.5 hours, collecting decoction, filter, filtrate is concentrated into relative density and is 1.04-1.06 (80 ℃ of surveys), and is standby.Radix Scutellariae decocts with water three times, the first time, 7 times of water gagings were 2 hours, each 5 times of water gaging of second and third time 1 hour, collecting decoction, filter, being concentrated into relative density is the clear paste of 1.05-1.08 (80 ℃ of surveys), adds 2mol/L hydrochloric acid adjust pH 1.5-2.0 in the time of 80 ℃, and 80 ℃ are incubated 1 hour, quiet to 24 hours, filter, get precipitation, standby.Remaining 91 parts of Concha Meretricis Seu Cyclinae powders, Plumbum preparatium, catechu, Olibanum, Myrrha, Pulvis Fellis Suis, Borneolum Syntheticum are pulverized mixing cross 100 mesh sieves, mix, grind evenly, take out through colloid mill with aforementioned standby extracting solution and precipitate, standby; The carbomer 934 of recipe quantity is evenly spread in the lapping liquid, make abundant swelling, placed 2 hours, with 80 ℃ of thermosols of ethyl hydroxybenzoate of Rhizoma Curcumae volatile oil and recipe quantity in the triethanolamine of recipe quantity, adding water dilutes in right amount, under the stirring of agitator, add in the swollen medicinal liquid of carbomer 934, add water to 5000 parts, stir, take out, fill, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101096755A CN100450528C (en) | 2006-08-16 | 2006-08-16 | Funing gel prepn. and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101096755A CN100450528C (en) | 2006-08-16 | 2006-08-16 | Funing gel prepn. and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1903351A true CN1903351A (en) | 2007-01-31 |
| CN100450528C CN100450528C (en) | 2009-01-14 |
Family
ID=37672813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101096755A Active CN100450528C (en) | 2006-08-16 | 2006-08-16 | Funing gel prepn. and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100450528C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461916B (en) * | 2008-08-11 | 2011-03-16 | 王雷 | External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same |
| CN103520339A (en) * | 2013-10-11 | 2014-01-22 | 哈尔滨欧替药业有限公司 | Funing expandable vaginal suppository, and preparation method and detection method thereof |
| CN105079124A (en) * | 2015-09-30 | 2015-11-25 | 杭州育福龙医疗器械有限公司 | Swelling and pain reducing gel paste |
| WO2019134159A1 (en) * | 2018-01-08 | 2019-07-11 | 刘琦 | Rectal mucosal administration preparation of pulsatilla chinensis (bge.) regel saponin b4 and preparation method therefor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1745837A (en) * | 2004-09-06 | 2006-03-15 | 毛友昌 | Funing preparation and its making method theref |
-
2006
- 2006-08-16 CN CNB2006101096755A patent/CN100450528C/en active Active
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461916B (en) * | 2008-08-11 | 2011-03-16 | 王雷 | External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same |
| CN103520339A (en) * | 2013-10-11 | 2014-01-22 | 哈尔滨欧替药业有限公司 | Funing expandable vaginal suppository, and preparation method and detection method thereof |
| CN103520339B (en) * | 2013-10-11 | 2014-11-26 | 哈尔滨欧替药业有限公司 | Funing expandable vaginal suppository, and preparation method and detection method thereof |
| CN105079124A (en) * | 2015-09-30 | 2015-11-25 | 杭州育福龙医疗器械有限公司 | Swelling and pain reducing gel paste |
| WO2019134159A1 (en) * | 2018-01-08 | 2019-07-11 | 刘琦 | Rectal mucosal administration preparation of pulsatilla chinensis (bge.) regel saponin b4 and preparation method therefor |
| US11253471B2 (en) | 2018-01-08 | 2022-02-22 | Qi Liu | Rectal mucosal administration preparation of Pulsatilla chinensis saponin B4 and preparation method therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100450528C (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1281356A (en) | Quickly soluble solid preparations | |
| CN1903351A (en) | Funing gel prepn. and its prepn. method | |
| CN1861080A (en) | Use of phytolaccagenin in preparing medicine for treating azoplasia | |
| CN100446753C (en) | Clotrimazole gel, and its prepn. method | |
| CN100341495C (en) | Solid dispersion and preoral combination of glibenclamide and preparation method | |
| CN1186336C (en) | Prepn and application in preparing medicine of fraxinus general coumarin | |
| CN1292750C (en) | Total alkaloid composition from plant and its pharmaceutical preparation | |
| CN1872852A (en) | Derivative of berberine, and prepartion method, composition of medication, and application | |
| CN101040891A (en) | Method of preparing tripterygium hypoglaucum (Levl) hutch alkaloids | |
| CN1861081A (en) | Use of phytolaccatoxin for preparing medicine to treat mazoplasia | |
| CN1406585A (en) | Medicinal composition for viral myocarditis | |
| CN1279912C (en) | Use of sinomenine | |
| CN1309376C (en) | Musk slow-controlled release preparation and preparation method thereof | |
| CN1634478A (en) | Tendril-leaved fritillary bulb loquat drop pills and preparation method thereof | |
| CN107126421A (en) | A kind of dextromethorphan chewable tablets | |
| CN1535972A (en) | New compound,its preparation method, medicine preparation using said compound as active component, its action and application | |
| CN1771989A (en) | Compound prepn for treating women's inflammation | |
| CN1310639C (en) | Effervescence tablet for treating gynecopathy and preparation method thereof | |
| CN1676130A (en) | Water-soluble medicine sublingual-medicating formulation | |
| CN1679675A (en) | Chuanhuang anti-inflammation drops for clearing away heat and detoxicating, and preparation thereof | |
| CN1562045A (en) | Doxycycline dripping pill | |
| CN1679669A (en) | Polygala dropping balls and preparation thereof | |
| CN1294902C (en) | Cough and asthma relieving drop pills prepared using dahurian rhododendron leaf | |
| CN114557992A (en) | Application of compound pharmaceutical composition in preparation of medicine for treating interstitial pneumonia | |
| CN1679671A (en) | Compound berberine dropping ball and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 100083 Haidian District, Xueyuan Road, No. 30, A building, room No. 15, room, room 15 Patentee after: COSCI MED-TECH Co.,Ltd. Address before: 100080, room 1410, satellite building, No. 63, Zhichun Road, Beijing, Haidian District Patentee before: COSCI MED-TECH Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20230403 Address after: 8639, Floor 6, Building 3, No. 3, Yongchang North Road, Daxing District, Beijing, 100176 Patentee after: Beijing Kexin Jurun Pharmaceutical Technology Co.,Ltd. Address before: 100083 room 15, 15 / F, block a, Tiangong building, 30 Xueyuan Road, Haidian District, Beijing Patentee before: COSCI MED-TECH Co.,Ltd. |
|
| TR01 | Transfer of patent right |